Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.19.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
STOCKHOLDERS' EQUITY (DEFICIT):  
Schedule of share-based compensation, stock options, activity
   

Shares

Underlying

Options

   

Weighted

Average

Exercise Price

   

Weighted

average

Remaining

Contractual Life

(years)

   

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2017     -     $ -       -       -  
Acquired in Reverse Merger     133,711       36.42       4.40       -  
Granted     68,347       12.24       9.76       -  
Outstanding at June 30, 2018     202,058     $ 25.74       8.49       -  
Schedule of share-based payment award, stock options, valuation assumptions
Fair value of common stock   $10.92-$13.26
Expected volatility   118.10% - 118.83%
Dividend yield   $0
Risk-free interest   2.87% - 3.00%
Expected life (years)   5.33
Schedule of common stock warrant activity
    Number of Warrants    

Weighted Average

Exercise Price

 
Outstanding, December 31, 2017     146,358     $ 59.04  
Acquired, H-1 warrants     50,744       29.04  
Acquired, H-3 warrants     14,001       33.12  
Granted, H-4 warrants(1)     447,383       3.60  
Granted, I warrants     73,178       13.80  
Retired, Merger Warrants     (146,357 )     59.04  
Outstanding, June 30, 2018     585,307     $ 16.98  

 

(1) Excludes 1,342,150 H-4 warrants representing 150% coverage of H-4 warrants granted.